3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Sarcoma
1
NET
1
Genitourinary
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Neuroendocrine Tumors
34
Pheochromocytoma
4
Paraganglioma
4
Carcinoma, Neuroendocrine
4
Sarcoma
3
Pancreatic Neoplasms
3
Neoplasms
3
Meningioma
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Carcinoid Tumor
3
Adenoma, Islet Cell
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neuroblastoma
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Neoplasm Metastasis
2
Melanoma
2
Medulloblastoma
2
Liver Neoplasms
2
Insulinoma
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Gastro-enteropancreatic neuroendocrine tumor
2
Digestive System Neoplasms
2
Colonic Neoplasms
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Glandular and Epithelial
×
NET
×
30 days
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled